Skip to main content
Diagnamed Holdings Corp. logo

Diagnamed Holdings Corp. — Investor Relations & Filings

Ticker · DMED ISIN · CA25245D1033 LEI · 529900UL67VSZMMIHW28 CSE Mining and quarrying
Open in API
Filings indexed 104 across all filing types
Latest filing 2025-05-28 Regulatory Filings
Country CA Canada
Listing CSE DMED

About Diagnamed Holdings Corp.

https://diagnamed.com/

Diagnamed Holdings Corp. is a clean-technology company focused on the discovery and production of naturally occurring geologic, or "white," hydrogen. The company employs advanced subsurface analytics and proprietary soil-gas survey methods to locate hydrogen accumulations in favorable geological settings. Its core strategy involves utilizing clean, non-electrolytic extraction technologies, including patented electromagnetic stimulation tools, to release hydrogen from iron-rich rock formations and depleted reservoirs, minimizing environmental impact and achieving low-cost production. Diagnamed is actively developing Canada's Natural Hydrogen Corridor, with exploration programs concentrated in the Timiskaming District of Ontario and Québec, aiming to supply sustainable fuel to industrial, municipal, and transportation sectors.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV2 “Venture Issuer Basic Certificate” under Canadian NI 52-109, which certifies review of the interim financial report and MD&A for the quarter ended March 31, 2025. It does not itself present financial results or management discussion, nor is it an announcement linking to a report. It is a regulatory certification form accompanying interim filings. There is no specific category for a certification form, so it falls under Regulatory Filings (RNS) as a miscellaneous regulatory submission.
2025-05-28 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV2 certification by the CFO for interim filings under Canadian securities rules. It is not the interim financial report or MD&A itself but a compliance/certification filing. This does not match earnings releases, MD&A narrative, or other specific filings—it is a regulatory certification filing. Therefore, it fits under the general “Regulatory Filings” category (RNS).
2025-05-28 English
Interim MD&A - English.pdf
Management Reports Classification · 1% confidence The document is titled “Interim Management’s Discussion and Analysis – Quarterly Highlights” for the three and six months ended March 31, 2025. It is a standalone MD&A prepared under NI 51-102 to accompany the interim financial statements. It does not include the full financial statements themselves but provides management’s detailed explanation of quarterly results, trends, risks, and outlook. Therefore it aligns with the Management Reports category (MDA), not the full Interim/Quarterly Report category.
2025-05-28 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Condensed Interim Consolidated Financial Statements' for Diagnamed Holdings Corp. for the three and six months ended March 31, 2025. It contains comprehensive financial statements (Statement of Financial Position, Statement of Loss/Income, Statement of Cash Flows, and Statement of Changes in Equity) along with detailed explanatory notes. This meets the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data for a period shorter than a full fiscal year. Q1 2025
2025-05-28 English
Notice of meeting - English.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a Notice of Annual General Meeting, providing shareholders with the meeting agenda, record date, proxy voting instructions, and details on how to submit proxies. It is part of the proxy solicitation materials sent to shareholders to request votes for the AGM. Therefore, it fits the 'Proxy Solicitation & Information Statement' category (PSI).
2025-03-07 English
Other.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a Voting Instruction Form (VIF) used to solicit and capture shareholder proxy voting instructions for an upcoming Annual General Meeting. It is not the actual proxy management circular itself but is part of the proxy solicitation process, requesting votes and providing voting options for meeting resolutions. Therefore, it falls under the “Proxy Solicitation & Information Statement” category (PSI).
2025-03-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.